Literature DB >> 1980561

Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium.

Y Okada1, Y Gonoji, I Nakanishi, H Nagase, T Hayakawa.   

Abstract

Degradation of fibrillar collagens is a central process in joint destruction in rheumatoid arthritis. Collagenase responsible for the collagenolysis has been immunolocalized on the extracellular matrix components at the cartilage/pannus junction in the rheumatoid joint, but very little is known about cellular source of the proteinase. In this paper monospecific antibodies against collagenase and tissue inhibitor of metalloproteinases (TIMP) were applied to rheumatoid and normal synovium to identify cells synthesizing and secreting the enzyme and its inhibitor. By treating the specimens with the monovalent ionophore, monensin, both collagenase and TIMP could be immunolocalized in hyperplastic synovial lining cells in rheumatoid synovium, but not in the cells of normal synovium. Dual immunolocalization studies demonstrated that the majority of the lining cells (approximately 64%) produce both collagenase and TIMP, while approximately 3% of the cells were positive only for collagenase, and 11% only for TIMP. Neither collagenase nor TIMP was immunolocalized on the extracellular matrix components in the synovia examined. These data suggest that synovial lining cells in rheumatoid arthritis secrete both collagenase and TIMP into the joint cavity. The role of collagenase in joint destruction in rheumatoid arthritis is discussed with reference to the regulation of the activity by TIMP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980561     DOI: 10.1007/bf02899418

Source DB:  PubMed          Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol        ISSN: 0340-6075


  18 in total

1.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.

Authors:  Y Yoshihara; H Nakamura; K Obata; H Yamada; T Hayakawa; K Fujikawa; Y Okada
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

Review 2.  Action mechanisms of complementary and alternative medicine therapies for rheumatoid arthritis.

Authors:  Imada Keisuke; Bao-lin Bian; Xiang-dong Li; Sato Takashi; Ito Akira
Journal:  Chin J Integr Med       Date:  2011-10       Impact factor: 1.978

3.  The role of interleukin 6 in the pathophysiology of rheumatoid arthritis.

Authors:  Srinivasan Srirangan; Ernest H Choy
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-10       Impact factor: 5.346

4.  Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and beta 2-microglobulin amyloidosis.

Authors:  K Ohashi; R Kawai; M Hara; Y Okada; S Tachibana; Y Ogura
Journal:  Virchows Arch       Date:  1996-04       Impact factor: 4.064

5.  Comparative studies of collagenase and stromelysin-1 expression by rheumatoid synoviocytes in vitro.

Authors:  L C Tetlow; M Lees; D E Woolley
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Immunolocalization of basic fibroblast growth factor and platelet-derived growth factor-A during adjuvant arthritis in the Lewis rat.

Authors:  Z Qu; M Picou; T T Dang; E Angell; S R Planck; C E Hart; J T Rosenbaum
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

7.  Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo.

Authors:  L C Tetlow; M Lees; Y Ogata; H Nagase; D E Woolley
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

8.  Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage.

Authors:  R M Hembry; M R Bagga; G Murphy; B Henderson; J J Reynolds
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

9.  Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis.

Authors:  S Maeda; T Sawai; M Uzuki; Y Takahashi; H Omoto; M Seki; M Sakurai
Journal:  Ann Rheum Dis       Date:  1995-12       Impact factor: 19.103

Review 10.  Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.

Authors:  Jean-Michel Dayer; Ernest Choy
Journal:  Rheumatology (Oxford)       Date:  2009-10-23       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.